MAPKAPK2 and Hepatic fibrosis: Taken together, our data indicate that MK2 inhibition decreases fibrotic gene expression and soluble factors, which are regulated by cytokines whose expression is upregulated during MK2 inhibition, thus suggesting a cytokine-mediated mechanism regulating liver fibrosis.